Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Cagrilintide for Sale > Cagrilintide 5mg + Semaglutide 5mg Blend Peptide | High Purity Research Reagent
Cagrilintide 5mg + Semaglutide 5mg Blend Peptide | High Purity Research Reagent buy - large image1
Cagrilintide 5mg + Semaglutide 5mg Blend Peptide | High Purity Research Reagent buy - image1
Cagrilintide 5mg + Semaglutide 5mg Blend Peptide | High Purity Research Reagent buy - image2
Cagrilintide 5mg + Semaglutide 5mg Blend Peptide | High Purity Research Reagent buy - image3
Cagrilintide 5mg + Semaglutide 5mg Blend Peptide | High Purity Research Reagent buy - image4
Cagrilintide 5mg + Semaglutide 5mg Blend Peptide | High Purity Research Reagent buy - image5

Cagrilintide 5mg + Semaglutide 5mg Blend Peptide | High Purity Research Reagent

60 Inquiries

Unit Price:

$138-140/UNIT FOB

Get Latest Price
CAS No.:

1415456-99-3

Grade:

Pharmaceutical Grade

Content:

99.9%

Port:

Guangdong

Packaging:

10mg/vials 10vials/box

Price valid (until):

2027-09-27

Company Type:
Trader
Location:
Hongkong, China
Qualification:
Main Products:

Tirzepatide,Retatrutide,Semaglutide,GHK-Cu

  • Product Description

  • Seller Information

  • Inquiry History

  • Description
    Items Specifications
    CAS NO.  1415456-99-3
    Product name  Cagrilintide 5mg + Semaglutide 5mg
    Purity 99.9%
    Packaging 10mg/vial, 10vials/box
    Payment term Alipay,USDT,USDC, Bitcoin, Bank transfer
    MOQ 10vials
    Shelf life 2 Years
    Certificate COA
    Delivery time within 48 hours after payment

    🧬 The Cutting-Edge "Dual-Action" Research Peptide Formula

    🔬 Why Our Blend? The Future of Peptide Research

    We didn't just mix two peptides together; we created a Synergistic Powerhouse.
    This formulation is specifically designed for researchers working on advanced metabolic regulation and body composition studies. The combination of Cagrilintide and Semaglutide represents the state-of-the-art in peptide science, offering a dual mechanism that outperforms single-target agents.

    Shop Cagrilintide 5mg + Semaglutide 5mg Blend Peptide | High Purity Research Reagent-Detailed Image 1
    Shop Cagrilintide 5mg + Semaglutide 5mg Blend Peptide | High Purity Research Reagent-Detailed Image 2
    Shop Cagrilintide 5mg + Semaglutide 5mg Blend Peptide | High Purity Research Reagent-Detailed Image 3
    Shop Cagrilintide 5mg + Semaglutide 5mg Blend Peptide | High Purity Research Reagent-Detailed Image 4
    Shop Cagrilintide 5mg + Semaglutide 5mg Blend Peptide | High Purity Research Reagent-Detailed Image 5
    Shop Cagrilintide 5mg + Semaglutide 5mg Blend Peptide | High Purity Research Reagent-Detailed Image 6


    💡 Core Research Advantages (Innovation Points)  


    1. 1. Gold-Standard Synergy:

      Cagrilintide, a long-acting amylin analog, pairs perfectly with Semaglutide, a potent GLP-1 receptor agonist. This blend creates a "1+1>2" effect, allowing researchers to explore synergistic pathways that single peptides cannot replicate.

    2. 2. Targeted & Efficient:

      Engineered for studies focusing on adipose (fat) tissue modulation and appetite regulatory mechanisms. Our formula delivers consistent results, making it ideal for pre-clinical trials and high-precision scientific experiments.

    3. 3. Ready-to-Use Convenience:

      Save weeks of lab preparation time! Each vial is precisely weighed and blended under sterile conditions. Eliminate weighing errors and cross-contamination risks; our ready-to-use format is trusted by top research institutions worldwide.


    Storage & Handling
    Store at -20°C or lower immediately upon receipt.
    Minimize repeated freeze-thaw cycles.
    Keep sealed in dry and dark conditions.
    Handle only by qualified laboratory personnel with proper protection









    Shop Cagrilintide 5mg + Semaglutide 5mg Blend Peptide | High Purity Research Reagent-Detailed Image 7
    Shop Cagrilintide 5mg + Semaglutide 5mg Blend Peptide | High Purity Research Reagent-Detailed Image 8
    Shop Cagrilintide 5mg + Semaglutide 5mg Blend Peptide | High Purity Research Reagent-Detailed Image 9
    Shop Cagrilintide 5mg + Semaglutide 5mg Blend Peptide | High Purity Research Reagent-Detailed Image 10


      Product Detail  


    🛡️ Quality & Safety Assurance
    Spartan Quality Control: Every batch undergoes rigorous testing by a third-party accredited lab. We provide a Certified COA with detailed HPLC and MS spectra, ensuring batch-to-batch consistency.
    Global Shipping Expertise: Packaged in moisture-proof, light-shielding containers with professional cold chain logistics. We ensure your research samples arrive 100% intact and fully active.
    📌 Important Note
    For Laboratory Research Use Only. This product is not intended for human consumption, veterinary use, or therapeutic applications.

    Shop Cagrilintide 5mg + Semaglutide 5mg Blend Peptide | High Purity Research Reagent-Detailed Image 11
    Shop Cagrilintide 5mg + Semaglutide 5mg Blend Peptide | High Purity Research Reagent-Detailed Image 12
    ECHEMI Editorial Reference
    Cagrilintide is an amylin-analog, now being developed in combination with the GLP-1 agonist semaglutide to achieve sustained weight loss in persons with overweight and obesity. This drug is an investigational therapy that reduced body weight in a phase 2 trial when administered as monotherapy in participants without diabetes and with a BMI of at least 30 kg/m2 or at least 27 kg/m2 with hypertension or dyslipidaemia[1-2].

    Basic Info
    Product Name:

    Cagrilintide

    Other Name:

    Cagrilintide;Cargliptin;Caglitide;Cagrilintide acetate;Cagrilintide peptide;Cagrilintide 5mg 10mg 15mg;Cagrilintide(Acetate form);Kagliptin

    CAS No.:

    1415456-99-3

    Molecular Weight:

    0

    EC Number:

    206-141-6

    Color/Form:

    White to off-white

    Categories:

    Polypeptide

    Research
    Class:

    Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

    Status:

    Investigational — Phase 3 (REDEFINE program, CagriSema combination)

    Mechanism:

    A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.

    Activity note:

    Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

    Source:

    MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

    Clinical Development:

    NCT05249895; NCT05249882

    References
    PubChem:

    PubChem

    Disclaimer:

    Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Tirzepatide,Retatrutide,Semaglutide,GHK-Cu

    Location:

    RM 701, UNIT 108, 7/F, TWR B NEW MANDARIN PLAZA 14 SCIENCE MUSEUM RD TSIM SHA TSUI HONG KONG

    Year of Establishment:

    2026

  • Inquiry History
    60 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Cagrlintide

    1 MT Jul 31, 2026
    United Kingdom

    cagrilintrude

    20 MG Jul 21, 2026
    United States

    Cagrilintide

    1 KG Jul 17, 2026
    United States

    Cagrilintide

    30 MG May 26, 2026
    United Kingdom

    CAGRILLINTED

    10  May 3, 2026
    Hongkong, China

    Cagrilintide

    100 MG Apr 22, 2026
    United Kingdom

    Cagrilintide

    1 KG Apr 14, 2026
    Ireland

    Cagrilintide

    10 PCS Apr 14, 2026
    United States

    Cargrilintide

    10 MG Mar 19, 2026
    United Kingdom

    cagrilintide

    10 MG Feb 18, 2026
    China

    CagriSema cagrilintide 2.5mg+Samaglutide2.5mg

    10 MG Jan 26, 2026
    South Korea

    Cagrilintide

    500 MG Jan 21, 2026
    Pakistan

    cagrilintide

    1 KG Dec 26, 2025
    United States

    Cagrilintide

    20 MG Dec 19, 2025
    United Kingdom

    Cagrilintide

    100 MG Dec 10, 2025
    Canada

    All peptides

    1001 MT Nov 12, 2025
    United States

    Cagrilintide

    10 MG Oct 13, 2024
    United States

    Cagrilintide

    1 MG Jun 3, 2024
    Australia

    Cagrilintide

    20 MG Aug 17, 2026
    United Kingdom

    Cagrilintide

    10 MG Jul 31, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.